Yan Yu

机构：Army Medical University, Harbin Medical University, Shanghai Jiao Tong University, Shanghai Chest Hospital, Third Affiliated Hospital of Harbin Medical University, Xinqiao Hospital, Chi Mei Medical Center, Army Medical College · ORCID：0000-0002-8840-9497

发表论文 83 篇 · 总被引 3871 次 · h-index 26

代表论文

• Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy (2025 · New England Journal of Medicine · 被引 268)
• Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma (2023 · Cell Reports Medicine · 被引 33)
• 653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors (2023 · Annals of Oncology · 被引 27)
• APE1 promotes radiation resistance against radiation-induced pyroptosis by inhibiting the STING pathway in lung adenocarcinoma (2023 · Translational Oncology · 被引 27)
• OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study (2023 · Journal of Thoracic Oncology · 被引 23)
• Astragalus polysaccharides sensitize ovarian cancer stem cells to PARPi by inhibiting mitophagy via PINK1/Parkin signaling (2024 · iScience · 被引 21)